SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520138-22-000548
Filing Date
2022-12-06
Accepted
2022-12-06 06:05:31
Documents
17
Period of Report
2022-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20221205_8k.htm   iXBRL 8-K 53515
2 EXHIBIT 99.1 bivi-20221205_8kex99z1.htm EX-99.1 49908
3 EXHIBIT 99.2 bivi-20221205_8kex99z2.htm EX-99.2 29391
7 GRAPHIC ex9-1_001.jpg GRAPHIC 38236
8 GRAPHIC ex9-1_002.jpg GRAPHIC 42742
9 GRAPHIC ex9-1_003.jpg GRAPHIC 25958
  Complete submission text file 0001520138-22-000548.txt   479197

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bivi-20221205.xsd EX-101.SCH 3239
5 XBRL LABEL FILE bivi-20221205_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bivi-20221205_pre.xml EX-101.PRE 22367
11 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20221205_8k_htm.xml XML 3605
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 221446630
SIC: 2834 Pharmaceutical Preparations